Overview Financials News + Filings Key Docs Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
|
|
Immix Biopharma, Inc.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/22/2023 |
8-K
| Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Departure of Directors or Certain Office...|
Docs:
|
"PRE-FUNDED WARRANT THESE SECURITIES REPRESENTED HEREBY AND THE SECURITIES ISSUABLE UPON EXERCISE OF THESE SECURITIES HAVE BEEN ACQUIRED FOR INVESTMENT AND HAVE NOT BEEN REGISTERED WITH THE UNITED STATES SECURITIES AND EXCHANGE COMMISSION UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR UNDER ANY APPLICABLE STATE SECURITIES LAWS. WITHOUT SUCH REGISTRATION, SUCH SECURITIES MAY NOT BE SOLD OR OTHERWISE TRANSFERRED AT ANY TIME WHATSOEVER UNLESS IN THE OPINION OF COUNSEL SATISFACTORY TO THE COMPANY REGISTRATION IS NOT REQUIRED FOR SUCH TRANSFER AND THAT SUCH TRANSFER WILL NOT BE IN VIOLATION OF THE APPLICABLE FEDERAL AND STATE SECURITIES LAWS OR ANY RULE OR REGULATION PROMULGATED THEREUNDER.. IMMIX BIOPHARMA, INC. PRE-FUNDED WARRANT TO PURCHASE COMMON STOCK Warrant No. Number of Shares: Origina...",
"SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement is entered into as of August 21, 2023 , by and between Immix Biopharma, Inc., a Delaware corporation , and the subscriber identified on the signature pages hereto . WHEREAS: The Company desires to issue and sell to the Subscriber such number of shares of the Company’ s common stock, par value $0.0001 per share and such number of pre-funded warrants in the form attached hereto as to purchase such number of shares of Common Stock as set forth on the signature page to this Agreement. NOW, THEREFORE, for and in consideration of the premises and the mutual covenants hereinafter set forth, the parties hereto do hereby agree as follows: SUBSCRIPTION 1.1 Subject to the terms and conditions hereinafter set forth, the Subscriber hereby..." |
|
| 07/14/2023 |
8-K
| Quarterly results |
| 06/08/2023 |
8-K
| Submission of Matters to a Vote of Security Holders Interactive Data |
| 03/22/2023 |
8-K
| Quarterly results |
| 03/13/2023 |
8-K/A
| Regulation FD Disclosure Interactive Data |
| 01/18/2023 |
8-K
| Quarterly results |
| 12/16/2022 |
8-K
| Investor presentation |
| 12/14/2022 |
8-K
| Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits Interactive Data |
| 06/09/2022 |
8-K
| Quarterly results |
| 01/19/2022 |
8-K
| Other Events, Financial Statements and Exhibits |
| 01/12/2022 |
8-K
| Other Events, Financial Statements and Exhibits |
| 01/03/2022 |
8-K
| Other Events, Financial Statements and Exhibits |
| 12/20/2021 |
8-K
| Quarterly results |
|
|